Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …

Gram-negative pathogens such as Klebsiella pneumoniae, Acinetobacter baumannii, and
Pseudomonas aeruginosa are the leading cause of nosocomial infections throughout the …

Increased expression of chromosomal genes for resistance-nodulation-cell division (RND)-
type efflux systems plays a major role in the multidrug resistance (MDR) of Acinetobacter …

We investigated the mechanisms of resistance to carbapenems, aminoglycosides,
glycylcyclines, tetracyclines, and quinolones in 90 multiresistant clinical strains of …

Because of its remarkable ability to acquire antibiotic resistance and to survive in
nosocomial environments, Acinetobacter baumannii has become a significant nosocomial …

Anti-pseudomonas aminoglycosides, such as amikacin and tobramycin, are used in the
treatment of Pseudomonas aeruginosa infections. However, their use is linked to the …

A literature review was undertaken to ascertain the molecular basis for tigecycline and
colistin resistance mechanisms and the experimental basis for the detection and delineation …

Tigecycline (TIG) exhibits broad-spectrum activity against many Gram-positive and Gram-
negative pathogens. However, clinical resistance has emerged recently and has been …

What is known and objective Acinetobacter baumannii is one of the most important
nosocomial pathogens with the ability to cause infections such as meningitis, pneumonia …

Objectives Tigecycline represents one of the last-line therapeutics to combat multidrug-
resistant bacterial pathogens, including VRE and MRSA. The German National Reference …